Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

ABT-639

Base Information Edit
ABT-639

Synonyms:ABT-639

Suppliers and Price of ABT-639
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Tocris
  • ABT639 ≥98%(HPLC)
  • 10
  • $ 220.00
  • DC Chemicals
  • ABT-639 >98%
  • 100 mg
  • $ 650.00
  • DC Chemicals
  • ABT-639 >98%
  • 250 mg
  • $ 1200.00
  • Crysdot
  • ABT-639 98+%
  • 50mg
  • $ 1042.00
  • Crysdot
  • ABT-639 98+%
  • 100mg
  • $ 1459.00
  • Crysdot
  • ABT-639 98+%
  • 10mg
  • $ 347.00
  • Crysdot
  • ABT-639 98+%
  • 5mg
  • $ 243.00
  • ChemScene
  • ABT-639 99.36%
  • 5mg
  • $ 420.00
  • ChemScene
  • ABT-639 99.36%
  • 1mg
  • $ 180.00
  • ChemScene
  • ABT-639 99.36%
  • 100mg
  • $ 2520.00
Total 18 raw suppliers
Chemical Property of ABT-639 Edit
Chemical Property:
  • Boiling Point:612.2±65.0 °C(Predicted) 
  • PKA:6.80±0.10(Predicted) 
  • Density:1.51±0.1 g/cm3(Predicted) 
Purity/Quality:

97% *data from raw suppliers

ABT639 ≥98%(HPLC) *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Description ABT-639 is a selective T-type calcium channel blocker with efficacy in a wide range of preclinical models of nociceptive and neuropathic pain.ABT-639 produces robust antinociceptive activity in experimental pain models at doses that do not significantly alter psychomotor or hemodynamic function in the rat. ABT-639 is a T-type calcium channel blocker. It inhibits inactivated-state Cav3.2 channels with an IC50 value of 2.3 μM and inactivated-state Cav3.1 and Cav3.3 channels by 50 and 39%, respectively, when used at a concentration of 10 μM. ABT-639 selectively inhibits inactivated-state T-type calcium currents over resting-state currents in rat dorsal root ganglion (DRG) neurons (IC50s = 7.6 and >30 μM, respectively). It reverses the hind limb grip force deficit in a rat model of osteoarthritic pain induced by monoiodoacetic acid (MIA; ED50 = 2 mg/kg). ABT-639 also increases the paw withdrawal threshold in rat spinal nerve ligation (SNL) and chronic constriction injury (CCI) models of neuropathic pain in a dose-dependent manner and attenuates cold allodynia in the CCI rat model when administered at doses greater than or equal to 3 mg/kg.
Technology Process of ABT-639

There total 4 articles about ABT-639 which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
2-chloro-4-fluoro-5-{[(2-fluorophenyl)amino]sulfonyl}benzoic acid; (8aR)-1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine; With HATU; In 2-methyltetrahydrofuran; ISOPROPYLAMIDE; at 20 ℃;
With sodium hydrogencarbonate; In 2-methyltetrahydrofuran; ISOPROPYLAMIDE;
Guidance literature:
2-Fluoroaniline; (R)-4-chloro-2-fluoro-5-(octahydropyrrolo[1,2-a]pyrazine-2-carbonyl)benzene-1-sulfonyl chloride; In dichloromethane; at 20 ℃;
With sodium carbonate; In methanol; dichloromethane; for 0.5h;
DOI:10.1021/acsmedchemlett.5b00023
Guidance literature:
Multi-step reaction with 3 steps
1.1: oxalyl dichloride; N,N-dimethyl-formamide / dichloromethane / 20 °C
2.1: dichloromethane / 1 h / 20 °C
2.2: 20 °C
3.1: dichloromethane / 20 °C
3.2: 0.5 h
With oxalyl dichloride; N,N-dimethyl-formamide; In dichloromethane;
DOI:10.1021/acsmedchemlett.5b00023
Post RFQ for Price